Forecasts data is unavailable for this security.
Consensus recommendation
- 17-Aug-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 2 analysts offering 12 month price targets for XORTX Therapeutics Inc have a median target of 12.18, with a high estimate of 14.04 and a low estimate of 10.32. The median estimate represents a 596.07% increase from the last price of 1.75.
High | 702.2% | 14.04 |
Med | 596.1% | 12.18 |
Low | 490.0% | 10.32 |
Earnings history & estimates in CAD
Average growth rate | -1.23% |
More ▼
Revenue history & estimates in CAD
Average growth rate | 0.00% |
More ▼